the clinical efficacy and tolerability of ciprofloxacin ( bay o 9867 ) , a new quinolone compound with broad antibacterial spectrum , was evaluated in 28 patients hospitalized in the first clinic of infectious diseases , university of naples , italy , for chronic liver disease and affected by respiratory ( rti ) or urinary tract infections ( uti ) .
C0008809
ciprofloxacin
C0042029
urinary tract infections